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Pregnant women are prone to iodine deficiency due to the increased need for iodine during ges-
tation. Progress has recently occurred in establishing serum thyroglobulin (Tg) as an iodine status
biomarker, but there is no accepted reference range for iodine sufficiency during pregnancy. An
observational study was conducted in 164 pregnant women. At week 16 of gestation urinary
iodine concentration (UIC), serum Tg, and thyroid functions were measured, and information on
the type of iodine supplementation and smoking were recorded. The parameters of those who
started iodine supplementation (≥150 μg/day) at least 4 weeks before pregnancy (n = 27), who
started at the detection of pregnancy (n = 51), and who had no iodine supplementation (n = 74)
were compared. Sufficient iodine supply was found in the studied population based on median
UIC (162 μg/L). Iodine supplementation ≥150 μg/day resulted in higher median UIC regardless
of its duration (nonusers: 130 μg/L vs. prepregnancy iodine starters: 240 μg/L, and pregnancy
iodine starters: 205 μg/L, p < .001, and p = .023, respectively). Median Tg value of pregnancy
starters was identical to that of nonusers (14.5 vs. 14.6 μg/L), whereas prepregnancy starters
had lowermedianTg (9.1 μg/L, p = .018). SerumTg concentration at week 16 of pregnancy showed
negative relationship (p = .010) with duration of iodine supplementation and positive relationship
(p = .008) with smoking, a known interfering factor of iodine metabolism, by multiple regression
analysis. SerumTg at week 16 of pregnancy may be a promising biomarker of preconceptual and
first trimester maternal iodine status, the critical early phase of foetal brain development.
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In spite of continuous efforts mild iodine deficiency remains an unre-
solved issue in many parts of the world (Lee, Cho, Shin, & Song,
2016; Völzke et al., 2016). Measurement of median urinary iodine con-
centration (UIC) is the recommended method to define iodine status at
the population level (World Health Organization, 2007). Due to its
large day‐to‐day variation, UIC, especially from spot urine samples, is- - - - - - - - - - - - - - - - - - - - - - - - - - -
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wileyonlinot appropriate for assessing iodine status in individual cases (König,
Andersson, Hotz, Aeberli, & Zimmermann, 2011; Soldin, 2002);
however, its application at the population level is supported by well‐
established criteria in various groups (World Health Organization,
2007). UIC reflects the recent iodine intake of the last 24–48 hr and
carries limited information on individual existing iodine stores (World
Health Organization, 2007). Thyroglobulin (Tg), the high molecular
weight precursor of thyroid hormone synthesis, has been- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
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Key messages
• Unlike urinary iodine concentration, serum thyroglobulin
(Tg) concentrations at week 16 of gestation reflects both
prepregnancy and first trimester iodine status covering
the critical period of foetal brain development.
• Using serumTg as a biomarker of iodine status, our data
verify that women of child‐bearing age living in iodine
deficient areas should start iodine supplementation
before pregnancy to maintain optimal iodine supply to
the thyroid during pregnancy.
• Weak or missing correlation between urinary iodine
concentration and serum Tg during pregnancy can be
the result of recent lifestyle changes (starting iodine
containing supplements and cessation of smoking)
associated with the detection of pregnancy.
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longer time due to its strong association with existing iodine stores in
euthyroid individuals (Bílek, Čeřovská, & Zamrazil, 2015; Knudsen
et al., 2001; Ma & Skeaff, 2014; Rasmussen et al., 2002; Vejbjerg
et al., 2009b). During the synthesis of thyroid hormones, coupled
iodinated tyrosine residues in the Tg molecule form triiodothyronine
(T3) and thyroxine (T4) and are subsequently released by proteolysis,
whereas a small amount of Tg also appears in the bloodstream (de
Vijlder, Ris‐Stalpers, & Vulsma, 1999; Herzog, 1983). SerumTg concen-
tration increases in iodine deficiency (Bílek et al., 2015; Knudsen et al.,
2001; Rasmussen et al., 2002; Vejbjerg et al., 2009b). Intervention
studies reveal that decrease of Tg concentration in response to iodine
supplementation is an indicator of the improvement in iodine status
(Benmiloud et al., 1994; Ma, Venn, Manning, Cameron, & Skeaff,
2016; Missler, Gutekunst, & Wood, 1994).
Pregnant women and their foetuses are highly sensitive to iodine
deficiency thereby giving a high priority to the monitoring of iodine
status at these life stages (Moog et al., 2017; Zimmermann, 2009). First
trimester of pregnancy is crucial from the point of maternal thyroid
hormone dependent foetal brain development (Bernal & Nunez,
1995; Moog et al., 2017). During pregnancy, a median UIC of
150–249 μg/L indicates iodine sufficiency (World Health Organiza-
tion, 2007). UIC normalized to urine creatinine concentration
(μg iodine/g creatinine; UIC/Cr) was found to be a better indicator of
iodine status during pregnancy (Li et al., 2016), as well as during
breastfeeding (Andersen, Møller, & Laurberg, 2014), due to reduced
variations caused by differences in urine volume.
Up till now, serum Tg measurement has not been widely used in
assessing iodine status during pregnancy. In addition to iodine supply,
thyroid function and thyroid size are also major determinants of the
serum Tg concentrations in nonpregnant adults (Knudsen et al.,
2001). It is not entirely clear how and to what extent the combined
effect of the gestational hormonal changes and the increased demand
for iodine is reflected in Tg concentrations. During pregnancy, the
secretory activity of the thyroid gland increases to meet the higher
demand for thyroid hormones (Moleti, Trimarchi, & Vermiglio,
2014); this reaches a plateau by week 16. Ending by the end of the
first trimester, high human chorionic gonadotropin (hCG) concentra-
tion has a transient thyrotropic effect (Hershman, 2004), which may
further interfere with the causal relationship between iodine intake
and serumTg concentration. The hCG concentration was a significant
predictor for Tg in a group of iodine deficient pregnant women
(Koukkou, Ilias, Mamalis, Adonakis, & Markou, 2016). Although recent
data suggest that a median Tg below 10 μg/L (with less than 3% of
individual values ≥44 μg/L) indicates iodine sufficiency in pregnant
women using a dried blood spot Tg assay (Stinca et al., 2017), no
accepted serumTg reference range has been established for maternal
iodine sufficiency.
We assumed that in pregnant women living in iodine deficient
area serum Tg at week 16 of gestation may carry information on
iodine intake in the first trimester, the critical phase of foetal brain
development. We aimed to verify if pregestational initiation of iodine
supplementation is more advantageous in comparison to supplemen-
tation start at the time of pregnancy detection using serum Tg as a
biomarker.2 | SUBJECTS AND METHODS
2.1 | Subjects
The study was conducted in Debrecen, the second largest city of
Hungary, in 2014. One hundred and eighty‐nine healthy pregnant
women visiting either the Clinical Center of the University of
Debrecen or Kenézy Gyula Hospital for routine pregnancy control,
without a personal history of thyroid disease, were invited to partici-
pate in the study at week 16 of gestation. The study protocol was
approved by the Institutional Ethics Committee of the University of
Debrecen. After informed consent was given, morning nonfasting spot
urine and blood samples were collected.2.2 | Laboratory measurements
After separation, serum samples were stored at −70 °C and urine sam-
ples were stored at −20 °C until analysis.
UIC was measured by inductively coupled plasma mass spectrom-
etry. Urine samples were diluted 10 times with 0.5% NH3 solution
before the analysis. Tellurium was used as internal standard
(20 μg/L). The diluted samples were analysed by a Thermo Scientific
XSeries 2 ICP‐MS (Thermo Fisher Scientific Inc., Bremen, Germany)
with a hexapole collision/reaction cell. Intra‐assay coefficients of vari-
ation (CV) were 2–5% and inter‐assay CV values were 10–15%.
Women were classified as smokers according to the concentration
of the nicotine metabolite, cotinine in their urine, measured by gas
chromatography–mass spectrometry as described by da Cunha et al.
(2013). A Thermo Scientific Finnigan Trace GC Ultra gas chromato-
graph with Finnigan Polaris Q mass spectrometer (Thermo Fisher
Scientific Inc., Bremen, Germany) was used. The cutoff value of urine
cotinine concentration for nicotine exposure was 100 ng/mL. Intra‐
assay CV values were 1–3% and inter‐assay CV values were 4–5%.
Urine creatinine concentration was measured immediately after
collection by Jaffé's method using a Cobas 6000 analyser (Roche
Diagnostics GmbH, Mannheim, Germany). Normal range was
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2–4%, respectively.
Serum Tg concentration was measured by chemiluminescent
immunoassay (LIAISON®‐Tg, DiaSorin S.p.A., Saluggia, Italy). The test
was calibrated using the reference standard CRM‐457. Nonpregnant
adult reference range was 0.2–70 ng/mL. Intra‐assay CV values were
3–6%, and inter‐assay CV values were 6–11%. Concentrations of
anti‐Tg antibodies (TgAb) were measured by radioimmunoassay with
DYNOtest anti‐Tg (BRAHMS Diagnostica GmbH, Hennigsdorf,
Germany) on a Ria‐mat 280 analyser (Stratec, Birkenfeld, Germany).
Intra‐assay CV values were 2–8% and inter‐assay CV values were
3–8%. Women with TgAb concentration above 60 IU/L were
considered TgAb positive.
Total hCG concentration was measured using enzyme‐linked
immunosorbent assay technique. The normal median value at week
16 of pregnancy in our laboratory is 28110 IU/L. Intra‐assay CV value
was 3.6%, and inter‐assay CV value was 5.9%.
Serum thyroid‐stimulating hormone (TSH), free T4 (fT4), free T3
(fT3) concentrations were measured using electrochemiluminescence
immunoassay on Modular Analytics E170 analyser (Roche Diagnostics
GmbH, Mannheim, Germany). Reference ranges were 0.3–4.2 mU/L
for TSH, 12–22 pmol/L for fT4 and 2.4–6.3 pmol/L for fT3. Intra‐assay
CV values were 1–2%, 2–5%, and 1–3%, inter‐assay CV values were
2–3%, 2–7%, and 2–8%, respectively.TABLE 1 Characteristics of the TgAb negative study population
(n = 164)
Parameters Values
Age (years) 30.2 ± 5.2
UIC (μg/L) 162 (92–290)
UIC/Cr (μg/g creatinine) 148 (94–254)
Tg (μg/L) 14.2 (8.5–24.7)
Tg ≥44 μg/L (n) 14 (9%)
TSH (mU/L) 1.8 (1.2–2.4)2.3 | Questionnaire
All subjects completed a questionnaire covering information on age,
current medications if any, and iodine supplementation: yes‐no
questions about regular use of iodized salt before and during current
pregnancy, regular use of pregnancy supplement or other dietary
supplement before and during current pregnancy with product names
and duration of use. Smoking habits were also recorded (never
smoked, quit smoking before conception, and quit smoking when
pregnancy was detected or current smoker).
fT4 (pmol/L) 13.3 (12.5–14.4)
fT3 (pmol/L) 4.8 (4.4–5.0)
hCG (IU/L)* 30921 (21926–43008)
Smoking status (verified by urine cotinine levels)
Never smoked (n) 81 (49.4%)
Former smoker (n) 40 (24.4%)
Current smoker (n) 43 (26.2%)
Iodine supplementation (self‐reported) preconceptual current
None (n) 71 (43.3%) 48 (29.3%)
Only iodized salt (n) 57 (34.8%) 30 (18.3%)
Only iodine containing pregnancy
supplement (n)
14 (8.5%) 46 (28.0%)
Both iodized salt and iodine containing
pregnancy supplement (n)
18 (11.0%) 36 (22.0%)
Not known (n) 4 (2.4%) 4 (2.4%)
Note. Age is expressed as mean ± standard deviation; laboratory parame-
ters are expressed as median and interquartile range (in parenthesis).
UIC = urinary iodine concentration; UIC/Cr = creatinine‐normalized urinary
iodine concentration; Tg = thyroglobulin; TSH = thyroid‐stimulating hor-
mone; fT4 = free thyroxine; fT3 = free triiodothyronine; hCG = human cho-
rionic gonadotropin.
*n = 159.2.4 | Statistical analysis
Statistical analysis was performed by STATISTICA 12 software
(Statsoft Inc. Tulsa, OK, USA). The distribution of continuous variables
was checked by the Kolmogorov–Smirnov test. For analysis of the
relationship between nonnormal distributed continuous variables
Spearman's rank‐order correlation test was performed. To compare
continuous variables between two or more subgroups, for normal dis-
tributed data Student's t test or one‐way analysis of variance was
applied, whereas for nonnormal distributed data MannWhitney‐U test
or Kruskal–Wallis H test was used as appropriate. Results were
expressed as mean ± standard deviation in case of normal distribution,
or median and 25th and 75th percentiles (interquartile range, IQR) in
case of nonnormal distribution. The stochastic relationships of discrete
variables were analysed by chi‐square test. Multiple linear regression
analysis was performed using logarithmically transformed serum Tg
(logTg) as a dependent variable and logTSH, loghCG, duration of iodine
supplementation (≥150 μg/day; coded as 0 = nonusers, 1 = pregnancy
iodine starters, and 2 = prepregnancy iodine starters) and smokingstatus (coded as 0 = never smoked, 1 = former smokers, and 2 = current
smokers) as potential predictor variables. p values below .05 were
considered statistically significant.3 | RESULTS
Twenty‐five (13%) of 189 women had elevated (>60 IU/L) TgAb con-
centration. Because endogenous TgAb is known to interfere with
immunological methods for measurement of Tg (Iervasi, Iervasi, Carpi,
& Zucchelli, 2006), women with positive TgAb were excluded from
further analysis. Characteristics of the TgAb negative subjects (study
subjects, n = 164) are shown in Table 1.
Significant positive correlation was found between fT4 and fT3
(rs = 0.333, p < .001). Neither TSH nor hCG was associated with any
other studied parameter. No correlations between serum Tg concen-
trations and TSH, fT3, fT4, or hCG concentrations were found. There
was only a weak negative correlation between serum Tg concentra-
tions and UIC/Cr (rs = −0.164, p = .035).3.1 | Iodine supplementation
Less than half of the women used iodized salt; their number did not
differ significantly before pregnancy (46%) and during pregnancy (40%;
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available over the counter in Hungary, and all, but one pregnancy sup-
plement contained iodine. Fifty‐five women (35%) reported regular use
of a pregnancy supplement before pregnancy, and 32 of them (20% of
all participants) were taking iodine‐containing pregnancy supplements.
Supplement use become more frequent after the detection of
pregnancy: 83% versus 35%, p < .001 for all supplements, and 50%
versus 20%, p < .001 for iodine containing supplements.
First, the impact of the self‐reported iodine supplementation at
inclusion (week 16 of pregnancy) was examined on the studied param-
eters. Women with unknown status of current iodine supplementation
(n = 4) were excluded from this analysis. Of the 160 women, 78, 2, 56,
17, and 7 reported using 0, 75, 150, 200, and 220 μg daily iodine,
respectively. In Table 2, results are shown based on the iodine content
of the actual pregnancy supplement. The current consumption of
iodized salt did not influence Tg, UIC or UIC/Cr concentrations (dataTABLE 2 Pregnant women are stratified according to the iodine suppleme
<150 μg iodine/day (n = 8
Age (years) 30.1 ± 5.7
UIC (μg/L) 128 (71–210)
UIC/Cr (μg/g creatinine) 115 (83–197)
Tg (μg/L) 14.7 (10.5–24.7)
Tg ≥44 μg/L (n) 6 (8%)
TSH (mU/L) 1.66 (1.03–2.01)
fT4 (pmol/L) 13.3 (12.4–14.3)
fT3 (pmol/L) 4.8 (4.5–5.0)
hCG (IU/L) 29375 (21645–41603
Smokers (n) never, former, current 37, 20, 23 (46%, 25%, 29%
Iodized salt consumption (n) 30 (38%)
Note. Age is expressed as mean ± standard deviation; laboratory parameters are
iodine concentration; UIC/Cr = creatinine‐normalized urinary iodine concentrati
roxine; fT3 = free triiodothyronine; hCG = human chorionic gonadotropin.
at test (age), chi‐square test (rate of smoking, iodized salt consumption, and Tg
TABLE 3 Results according to the duration of iodine containing (≥150 μg/
Nonusers (n = 74) Pregnancy
Start of iodine supplementation n.a. At the time of d
Duration (weeks) 0 10 (
Age (years) 29.8 ± 5.8 30
UIC (μg/L) 130 (75–212) 240 (
UIC/Cr (μg/g creatinine) 113 (84–199) 193 (
Tg (μg/L) 14.6 (10.7–26.2) 14.5 (
Tg ≥44 μg/L (n) 6 (8%) 5 (
TSH (mU/L) 1.62 (0.99–2.01) 1.97 (
fT4 (pmol/L) 13.3 (12.5–14.4) 13.2 (
fT3 (pmol/L) 4.8 (4.4–5.0) 4.6 (
hCG (IU/L) 28391 (21645–40760) 33029 (
Iodized salt consumption (n) 26 (35%) 21 (
Smokers (n) 23 (31%) 14 (
Note. Age is expressed as mean ± standard deviation; laboratory parameters and
quartile range (in parenthesis). UIC = urinary iodine concentration; UIC/Cr =
TSH = thyroid‐stimulating hormone; fT4 = free thyroxine; fT3 = free triiodothy
aAnalysis of variance (age), chi‐square test (rate of smoking and Tg ≥44 μg/L), anot shown). Unlike in the ≥150 μg iodine/day group, the UIC of the
<150 μg iodine/day group failed to reach iodine sufficiency (lower limit
of sufficient median UIC in pregnancy by WHO definition is 150 μg/L).
Serum Tg showed mild iodine deficiency (using cutoff value: 10 μg/L
from Stinca et al., 2017) in both groups (Table 2). The TSH concentra-
tions were higher in the group with ≥150 μg/day iodine intake. Next,
we aimed at testing the effect of prepregnancy ≥150 μg daily iodine
supplementation. Women were stratified according to the reported
duration of iodine containing pregnancy supplement use: nonusers,
pregnancy starters (supplementation started at the time of detection
of pregnancy), and prepregnancy starters (supplementation started at
least 4 weeks before pregnancy; Table 3). Women with unknown sta-
tus of iodine supplementation before or during pregnancy (n = 8), and
women who had taken iodine containing supplements before preg-
nancy and switched to pregnancy supplements without iodine at the
time of detection of pregnancy (n = 4) were excluded from this partntation at inclusion (week 16 of pregnancy)
0) ≥150 μg iodine/day (n = 80) p valuea
30.4 ± 4.8 .708
239 (141–365) <.001
197 (133–297) <.001
12.2 (6.9–24.9) .070
7 (9%) .772
1.89 (1.40–2.68) .003
13.3 (12.5–14.3) .914
4.7 (4.4–5.0) .268
) 33732 (23612–44414) .406
) 41, 20, 19 (51%, 25%, 24%) .746
36 (45%) .335
expressed as median and interquartile range (in parenthesis). UIC = urinary
on; Tg = thyroglobulin; TSH = thyroid‐stimulating hormone; fT4 = free thy-
≥44 μg/L) and Mann–Whitney‐U test (other parameters).
day) pregnancy supplement consumption
starters (n = 51) Prepregnancy starters (n = 27) p valuea
etection of pregnancy At least 4 weeks before pregnancy n.a.
5–12) 25 (20–33) <.001
.2 ± 5.3 30.9 ± 4.0 .641
145–360) 205 (104–492) <.001
131–315) 202 (128–289) <.001
8.3–26.3) 9.1 (4.8–20.4) .022
10%) 1 (4%) .634
1.4–2.78) 1.72 (1.03–2.63) .006
12.5–14.3) 13.9 (12.0–14.7) .923
4.3–5.0) 4.8 (4.5–5.1) .282
20801–44414) 34856 (27267–43289) .419
41%) 14 (52%) .311
28%) 5 (19%) .458
the duration of iodine supplement use are expressed as median and inter-
creatinine‐normalized urinary iodine concentration; Tg = thyroglobulin;
ronine; hCG = human chorionic gonadotropin; n.a. = not applicable.
nd Kruskal–Wallis H test (other parameters).
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25 weeks in pregnancy starters and prepregnancy starters, respec-
tively. Iodine supplementation ≥150 μg/day, resulted in higher UIC
and UIC/Cr compared to nonusers, regardless of its duration. How-
ever, prepregnancy starters had lower serum Tg concentrations than
pregnancy starters, and the Tg concentrations of pregnancy starters
were identical to those of nonusers. Only the group of prepregnancy
starters had median serum Tg value below 10 μg/L. TSH was slightly
increased in pregnancy starters (Table 3). The results of the post hoc
tests are shown in Figure 1.3.2 | Smoking status
Smoking status was verified by urine cotinine concentrations. All 22
women who reported current smoking had urine cotinine concentra-
tions above 100 ng/L. Sixty‐six of the 189 women reported that they
had quit smoking before pregnancy or when pregnancy was detected;
however, 21 of them had a urine cotinine concentration above
100 ng/L and were classified as smokers for further analysis. Median uri-
nary cotinine concentration in smokers was 724 (IQR: 212–1330) ng/L.
To test the effects of tobacco smoking, nonsmokers, including
women who never smoked, had quit smoking before conception, or
had quit smoking when pregnancy was detected were compared to
current smokers. Although there was no difference between smokersFIGURE 1 The effect of the duration of ≥150 μg/day iodine containing p
(TSH) concentrations, (b) urinary iodine concentration (UIC), (c) creatinine‐n
concentrations. Pregnancy starters: women who started iodine supplemen
women who started iodine supplementation at least 4 weeks before pregn
Results of the post hoc tests after Kruskal Wallis H test: #p = .020; *p < .00and nonsmokers in UIC and UIC/Cr, both the serumTg concentrations
of smokers and the percentage of elevated Tg (≥44 μg/L) were mark-
edly higher in the smokers' group. TSH and hCG concentrations were
lower with a slight increase in fT3 compared to nonsmokers
(Table 4).
Nonsmokers were further divided into subgroups of “never
smoked” and “former smokers”, that is, smokers who have quit
smoking. According to the results of the post hoc test, serum Tg con-
centrations of current smokers were significantly higher compared to
the concentrations of those who never smoked (21.1, IQR:
10.2–39.6 vs. 11.7, IQR: 7.2–18.6, p = .003), whereas former smokers
presented an intermediate median Tg concentration (16.8 IQR:
9.9–25.9). Although smoking habits influence serumTg level, exclusion
of smokers did not change our findings with respect to the role of
iodine supplementation (data not shown).
The result of the multiple regression analysis for logTg using
logTSH, loghCG, duration of iodine supplementation ≥150 μg/day,
and smoking status as predictor variables was F(4,143) = 4.47,
p = .002, adjusted R2 = 0.09. Beta coefficients with 95% confidence
intervals were 0.01 [−0.15, 0.16] for logTSH, −0.06 [−0.22, 0.10] for
loghCG, −0.21 [−0.37, −0.05] for duration of iodine supplementation
and 0.22 [0.06, 0.38] for smoking status. Duration of iodine supple-
mentation (≥150 μg/day) and smoking status were significant predic-
tors of serum Tg concentration (p = .010 and p = .008, respectively),regnancy supplement consumption on (a) thyroid‐stimulating hormone
ormalized UIC (UIC/Cr), and (d) serum thyroglobulin (Tg)
tation at the time of detection of pregnancy; prepregnancy starters:
ancy. Median, interquartile range, and the 5–95% ranges are shown.
5; **p < .001
TABLE 4 The effect of smoking on the studied parameters
Nonsmokers (n = 121) Smokers (n = 43) p valuea
Age (years) 30.4 ± 4.7 29.8 ± 6.6 .495
UIC (μg/L) 161 (92–290) 168 (119–286) .575
UIC/Cr (μg/g creatinine) 155 (97–250) 125 (90–255) .307
Tg (μg/L) 12.3 (7.9–21.7) 21.1 (10.2–39.6) .006
Tg ≥44 μg/L (n) 5 (4%) 9 (21%) <.001
TSH (mU/L) 1.80 (1.35–2.40) 1.44 (0.88–2.10) .040
fT4 (pmol/L) 13.3 (12.4–14.2) 13.3 (12.6–14.6) .359
fT3 (pmol/L) 4.7 (4.4–5.0) 4.9 (4.5–5.1) .045
hCG (IU/L) 34013 (23472–44836) 27548 (18834–34856) .021
Note. Age is expressed as mean ± standard deviation; laboratory parameters are expressed as median and interquartile range (in parenthesis). UIC = urinary
iodine concentration; UIC/Cr = creatinine‐normalized urinary iodine concentration; Tg = thyroglobulin; TSH = thyroid‐stimulating hormone; fT4 = free
thyroxine; fT3 = free triiodothyronine; hCG = human chorionic gonadotropin.
at test (age), chi‐square test (rate of Tg ≥44 μg/L) and Mann–Whitney‐U test (other parameters).
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respectively).4 | DISCUSSION
Mild iodine deficiency has been the iodine status of Hungary for
decades. Although the use of iodized salt remains voluntary in Hungary
and is not backed by iodine deficiency disorders (IDD) prevention and
monitoring programs, iodine supplementation during pregnancy in the
form of pregnancy multivitamins has become widely accepted. In this
study, our aim was to compare UIC, UIC/Cr, and serum Tg as
biomarkers of iodine supply in pregnant women in a geographical
region where previously iodine deficiency had been found (Mezosi
et al., 2000).
Week 16 of pregnancy was chosen for sample collection to avoid
the potential thyroid stimulatory effect of the peaking hCG around
week 12 (Moleti et al., 2014), to represent the iodine supply at early
gestation, which is known to be critical from the point of foetal brain
development (Moog et al., 2017), and because the growing demand
for thyroid hormones during early pregnancy reaches its plateau by
week 16 (Moleti et al., 2014).
We found sufficient iodine supply based on UIC according to the
WHO criteria (World Health Organization, 2007) and mild iodine defi-
ciency based on serum Tg using the cutoff values published by Stinca
et al. (2017) in pregnant women at week 16 of pregnancy.
Further, there was only a weak correlation betweenTg and creatinine‐
normalized UIC in the studied population. There are several possible
explanations for this. Number one, UIC, at least in mild to moderate
iodine deficiency, is largely dependent on short term iodine supply,
whereas Tg values reflect a longer time period and existing iodine
stores. Indeed, when we analysed UIC and serum Tg concentrations
according to the duration of iodine supplementation, we found that
UIC was more dependent on current iodine supplementation, whereas
serumTg was rather dependent on the duration of iodine supplementa-
tion: medianTg concentration of those who started iodine supplemen-
tation at the time of pregnancy detection was similar to that of
nonusers, whereas their UIC and UIC/Cr were close to that of
prepregnancy starters (Figure 1b–d). Second, the actual daily iodineintake may fluctuate due to the diet and the varying compliance in
iodine supplementation, which is immediately reflected in the UIC.
The household use of iodized salt alone failed to exert any effect on
either UIC or Tg concentrations. Our data show that iodine containing
pregnancy supplements contribute significantly to the optimum urinary
iodine excretion; however, the loading of iodine stores, as reflected in
Tg concentrations is only achieved by starting supplementation before
pregnancy. This finding reinforces the importance of preconceptual
iodine supplementation. According to our results, only iodine supple-
mentation initiated in the pregestational period was sufficient to
achieve optimum serumTg by the week 16 of gestation at the popula-
tion level. This finding is in line with a previous randomized controlled
trial when the authors found that 24 weeks of iodine supplementation
(150 μg/day) was needed to observe a fall of median serum Tg below
the cut‐off value in iodine deficient adults (Ma et al., 2016).
Serum TSH concentrations of those who started iodine supple-
mentation at the time of detection of pregnancy, but not in
prepregnancy starters were significantly higher compared to nonusers.
These results are consonant with others who found UIC‐related incre-
ment in serumTSH concentrations corresponding to the rising regional
iodine intake (Guan et al., 2008) or an increase in serumTSH in relation
to the introduction of mandatory salt iodization (Vejbjerg et al., 2009a).
We assume that higher TSH concentrations are part of the adaptation
process to the recently increased iodine intake. This further confirms
the need for iodine supplementation in women of child‐bearing age
living in iodine deficient areas to maintain optimal thyroid function,
at least until iodine sufficiency is achieved at the population level.
Women who reported themselves as nonsmokers and presented a
high cotinine concentration were either trying to hide their inability to
cease smoking or, alternately, were passive smokers. For classification
and data analysis, the actual cotinine concentration was used because
the interference of smoking with iodine metabolism was assumed to
be independent of the active or passive smoke intake route.
Tobacco smoking has significant effects on thyroid function
(Wiersinga, 2013). Large population‐based studies revealed that
smokers had significantly lower serum TSH and higher fT4 and fT3
concentrations than nonsmokers in the general population (Belin,
Astor, Powe, & Ladenson, 2004; Jorde & Sundsfjord, 2006). In the
Northern Finland Birth Cohort smoking in the second trimester was
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found in serumTSH concentrations between smokers and nonsmokers
(Männistö et al., 2012). We found significantly lower serum TSH and
higher fT3 concentrations in current smokers compared to non-
smokers during pregnancy. Similarly to previous observations
(Korevaar et al., 2015), significantly lower median hCG concentration
was found in smokers than in nonsmokers. Therefore, in addition to
the known effect on iodine utilization due to the competitive inhibition
of the sodium‐iodide symporter by thiocyanate (Dohán et al., 2003),
smoking leads to hCG concentration reduction. Because hCG
stimulates sodium‐iodide symporter expression in cytotrophoblast
cells (Arturi et al., 2002), smoking may further reduce iodine transfer
across the placenta through decrease in hCG concentration.
Several studies suggest that maternal smoking increases serum
and cord blood Tg concentrations during pregnancy (Andersen et al.,
2013; Brucker‐Davis et al., 2012; Hiéronimus et al., 2013). In subgroup
analysis, we found that Tg concentrations of those who never smoked
is lower compared to current smokers. We found that the length of the
nonsmoker status before conception is important in this respect.
According to our results, smoking status is a major contributor to
serum Tg concentration in the second trimester, with no impact on
urinary iodine. We believe that cigarette smoke interferes with iodine
utilization by the thyroid, whereas iodine absorption and UIC are less
influenced.
The simultaneous measurement of serum Tg, in addition to the
UIC based assessment, may provide useful information on iodine
status during pregnancy. This is in sharp contrast with the recent data
of Li et al. (2016) and Koukkou et al. (2016), which revealed inconclu-
siveTg data on a comparable size cohort of pregnant women. We think
that the sampling time is important; whereas our pregnant women
group was uniform in this respect, as all samples were collected at
week 16 of gestation, the other studies were more heterogeneous in
this respect including women between 8 and 36 weeks of pregnancy.
This may mean that our conclusions cannot be extended to other
pregnancy weeks, as the timing of sample collection at other
pregnancy weeks may result in different Tg reference values.
Comparisons of theTg studies are difficult, primarily due to analyt-
ical issues (Iervasi et al., 2006). Heterogeneity of the detected Tg epi-
topes leads to high inter‐assay variation, which can be partly reduced
by assay standardization with the certified Tg reference material we
have used, CRM‐457 (Feldt‐Rasmussen et al., 1996). The presence of
TgAb in the serum interferes with immunoassays for Tg measurement
potentially resulting in false high or false low results (Iervasi et al.,
2006; Mariotti et al., 1995). This can be avoided by excluding TgAb
positive subjects. However, according to the data of others (Stinca
et al., 2017; Vejbjerg et al., 2009b) exclusion of TgAb positive cases
did not alter their conclusions on the relationship between iodine
nutrition and Tg in a population context. We screened the sera for
TgAb and TgAb positive subjects were excluded. However, the
inclusion of the TgAb positive cases would not have influenced the
results with respect to the effect of iodine supplementation on iodine
status biomarkers (data not shown).
In this study, we have shown that Tg is a useful marker of the
iodine economy of the thyroid gland at week 16 of pregnancy. Accord-
ing to our findings, Tg concentration carries information on iodinesupply of a longer period, which includes the pregestational months,
compared with UIC that is rather dependent on recent iodine supply.
The effect of smoking, a well‐known factor interfering with thyroid
hormone synthesis, is reflected inTg concentration whereas UIC is less
affected. Thus, the information carried by Tg at week 16 of pregnancy
may outweigh that of UIC; we suspect that the actual iodine store of
the thyroid is a major determinant of Tg, whereas UIC is rather depen-
dent on the iodine intake of the last days. Although we aimed to test
iodine supply at the population level, it is highly possible that, unlike
UIC, Tg may serve as a marker of the individual iodine supply. To clarify
this, further studies are warranted.
Our study has several limitations. Due to the relatively small sam-
ple size, certain effects may have been overlooked. Sociodemographic
information was not collected and the observational nature of the
study did not allow us to reduce the effect of socioeconomic factors.
Higher maternal socioeconomic status has been linked to access to
better nutrition (Novaković et al., 2014) and health care (Larrañaga
et al., 2013) and, in iodine deficient areas, to higher iodine intake
(Zimmermann, 2013). Indeed, we found that the prevalence of
iodised salt use was higher and the prevalence of smoking was
lower in prepregnancy starters compared to pregnancy starters
(i.e., prepregnancy starters are likely to be more health conscious);
although these differences were not significant, they could have
contributed to the lower serum Tg concentrations in the group of
prepregnancy starters.
The use of serumTg as a biomarker of iodine status with a 10 μg/L
cutoff value seems to be appropriate in pregnant women at week 16 of
gestation. Starting iodine containing pregnancy supplements and/or
cessation of smoking at the time of detection of pregnancy does not
result in significant change in serumTg concentrations by week 16 of
pregnancy, when iodine supplementation is already reflected in UIC.
Even so, thyroid economy may be better reflected in Tg than UIC in
pregnancy; serumTg concentration at week 16 of pregnancy may carry
information on maternal iodine status of the previous months,
including the critical period of foetal brain development.
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